CRVO CervoMed Inc

Price (delayed)

$3.1

Market cap

$28.7M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.28

Enterprise value

$20.76M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 21

diffusion pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. the company is developing ...

Highlights
CervoMed's gross profit has plunged by 78% YoY and by 48% from the previous quarter
The revenue has shrunk by 78% YoY and by 48% QoQ

Key stats

What are the main financial stats of CRVO

CRVO stock price

How has the CervoMed stock price performed over time
Intraday
4.38%
1 week
-1.27%
1 month
-16.22%
1 year
-58.56%
YTD
-60.76%
QTD
-21.32%

Financial performance

How have CervoMed's revenue and profit performed over time
Revenue
$2.09M
Gross profit
$2.09M
Operating income
-$31.1M
Net income
-$30.04M
Gross margin
100%
Net margin
-1,437.8%
The net margin has plunged by 114% from the previous quarter
The operating margin has plunged by 111% from the previous quarter
CervoMed's gross profit has plunged by 78% YoY and by 48% from the previous quarter
The revenue has shrunk by 78% YoY and by 48% QoQ

Price vs fundamentals

How does CRVO's price correlate with its fundamentals

Growth

What is CervoMed's growth rate over time

Valuation

What is CervoMed stock price valuation
P/E
N/A
P/B
2.7
P/S
13.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
9.94
CervoMed's EPS has shrunk by 50% YoY and by 10% QoQ
The company's equity has shrunk by 69% YoY and by 42% QoQ
The P/B is 19% below the 5-year quarterly average of 3.2 and 14% below the last 4 quarters average of 3.0
The revenue has shrunk by 78% YoY and by 48% QoQ
The stock's price to sales (P/S) is 3.9% less than its last 4 quarters average of 13.7

Efficiency

How efficient is CervoMed business performance
The ROA has plunged by 177% YoY and by 36% from the previous quarter
CervoMed's return on sales has shrunk by 114% QoQ
The company's return on invested capital has shrunk by 55% QoQ
The return on equity has declined by 42% since the previous quarter

Dividends

What is CRVO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CRVO.

Financial health

How did CervoMed financials performed over time
The company's quick ratio has shrunk by 69% YoY and by 37% QoQ
The current ratio has plunged by 66% YoY and by 32% from the previous quarter
The debt is 100% less than the equity
The company's equity has shrunk by 69% YoY and by 42% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.